Zimmer Biomet Holdings (ZBH) Tops Q2 EPS by 9c, provides guidance

Zimmer Biomet Holdings (NYSE: ZBH) reported Q2 EPS of $2.07, $0.09 better than the analyst estimate of $1.98. Revenue for the quarter came in at $2.08 billion versus the consensus estimate of $2.06 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2025 EPS of $8.10-$8.30, versus the consensus of $7.99.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
• C3.ai (AI) Tops Q4 EPS by 5c, Beats on Revenue; Offers FY27 Revenue Guidance
• RBC Capital on Veeva Systems (VEEV) Amid After Hours Selloff on Earnings: 'we are surprised to see shares trade down'